VIM, vimentin, 7431

N. diseases: 644; N. variants: 6
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C3805411
Disease: CATARACT 30
CATARACT 30 		0.800 CausalMutation disease CLINVAR
CUI: C3805411
Disease: CATARACT 30
CATARACT 30 		0.800 Biomarker disease GENOMICS_ENGLAND
CUI: C3805411
Disease: CATARACT 30
CATARACT 30 		0.800 Biomarker disease MGD
CUI: C1833118
Disease: Cataract, Pulverulent
Cataract, Pulverulent 		0.600 Biomarker disease MGD
CUI: C1833118
Disease: Cataract, Pulverulent
Cataract, Pulverulent 		0.600 Biomarker disease HPO
CUI: C1852438
Disease: CATARACT, COPPOCK-LIKE
CATARACT, COPPOCK-LIKE 		0.500 Biomarker disease MGD
CUI: C0009691
Disease: Congenital cataract
Congenital cataract 		0.310 Biomarker disease MGD
CUI: C1861827
Disease: Cataract, Nuclear Diffuse Nonprogressive
Cataract, Nuclear Diffuse Nonprogressive 		0.300 Biomarker disease CTD_human
CUI: C1850191
Disease: Posterior polar cataract
Posterior polar cataract 		0.100 Biomarker phenotype HPO
CUI: C4024821
Disease: Diffuse nuclear cataract
Diffuse nuclear cataract 		0.100 Biomarker disease HPO
CUI: C0006118
Disease: Brain Neoplasms
Brain Neoplasms 		0.020 AlteredExpression group BEFREE This first preliminary report of H3, Vimentin and MYC gene expression in brain tumors demonstrates that malignant cells are characterized by a different gene expression and different growth potentials. 1317500 1992
CUI: C0027651
Disease: Neoplasms
Neoplasms 		0.100 AlteredExpression group BEFREE Both cell lines exhibited tumor cell morphology and growth kinetics and showed variable expression of glial fibrillary acidic protein (GFAP), S-100, fibronectin and vimentin. 1320358 1992
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma 		0.070 AlteredExpression disease BEFREE Six independent clonal isolates from a morphologically heterogeneous human neuroblastoma cell line stably expressed several products of the human amyloid precursor protein (APP) from an introduced DNA construct; the "substrate-adherent" phenotype (fibroblast-like cells) predominated in all 6; these displayed immunoreactivity of vimentin, but little to no reactivity of neuron-specific enolase. 1334198 1992
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma 		0.070 AlteredExpression disease BEFREE Six independent clonal isolates from a morphologically heterogeneous human neuroblastoma cell line stably expressed several products of the human amyloid precursor protein (APP) from an introduced DNA construct; the "substrate-adherent" phenotype (fibroblast-like cells) predominated in all 6; these displayed immunoreactivity of vimentin, but little to no reactivity of neuron-specific enolase. 1334198 1992
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma 		0.070 AlteredExpression disease BEFREE Six independent clonal isolates from a morphologically heterogeneous human neuroblastoma cell line stably expressed several products of the human amyloid precursor protein (APP) from an introduced DNA construct; the "substrate-adherent" phenotype (fibroblast-like cells) predominated in all 6; these displayed immunoreactivity of vimentin, but little to no reactivity of neuron-specific enolase. 1334198 1992
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast 		0.400 AlteredExpression disease BEFREE Fibroblastoid, vimentin-expressing breast cancer cell lines are more invasive in vitro and in vivo (E. W. Thompson, S. Paik, N. Brunner, C. L. Sommers, G. Zugmaier, R. Clarke, T. B. Shima, J. Torri, S. Donahue, M. E. Lippman, G. R. Martin, and R. B. Dickson, J.Cell.Physiol., 150: 534-544, 1992). 1382837 1992
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma 		0.400 AlteredExpression disease BEFREE Fibroblastoid, vimentin-expressing breast cancer cell lines are more invasive in vitro and in vivo (E. W. Thompson, S. Paik, N. Brunner, C. L. Sommers, G. Zugmaier, R. Clarke, T. B. Shima, J. Torri, S. Donahue, M. E. Lippman, G. R. Martin, and R. B. Dickson, J.Cell.Physiol., 150: 534-544, 1992). 1382837 1992
CUI: C0027651
Disease: Neoplasms
Neoplasms 		0.100 Biomarker group BEFREE Desmin was negative in other nonskeletal muscle origin tumors while vimentin was present in all tumors examined. 1434543 1992
CUI: C0025500
Disease: Mesothelioma
Mesothelioma 		0.040 Biomarker disease BEFREE The PAS and CEA reactions are negative but the vimentin and cytokeratin are positive in mesothelioma. 1464814 1993
CUI: C0027651
Disease: Neoplasms
Neoplasms 		0.100 Biomarker group BEFREE For comparison with reg, alpha-1-antitrypsin (AAT), lysozyme, chromogranin A (CMG), CA 19-9, carcinoembryonic antigen (CEA), cytokeratin, vimentin, and alpha-fetoprotein (AFP) were assessed in those tumors. 1525759 1992
CUI: C0334357
Disease: Papillary cystic tumor
Papillary cystic tumor 		0.010 Biomarker disease BEFREE A solid and cystic tumor had strongly positive results for AAT and vimentin and focally positive results for CMG and pancreatic hormones. 1525759 1992
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast 		0.400 Biomarker disease BEFREE We have explored the relationships between ER, VIM, and invasiveness in human breast cancer cell lines. 1537883 1992
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma 		0.400 Biomarker disease BEFREE We have explored the relationships between ER, VIM, and invasiveness in human breast cancer cell lines. 1537883 1992
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion 		0.100 Biomarker phenotype BEFREE Hs578T cells (ER-/VIM+) showed hematogenous dissemination to the lungs in one of five mice, but lacked local invasion. 1537883 1992
CUI: C0027651
Disease: Neoplasms
Neoplasms 		0.100 AlteredExpression group BEFREE Differential expression of vimentin in rat prostatic tumors. 1540169 1992